Definitions

Sorry, no definitions found. You may find more data at exforge.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word Exforge.

Examples

  • Other strong performers included diabetes drug Galvus and high blood pressure treatment Exforge, which helped Novartis balance the partial patent loss of heart medicine Diovan and cancer medicine Femara.

    Eye Care Boosts Novartis Goran Mijuk 2011

  • Drug maker Novartis says the U.S. Food and Drug Administration has given tentative approval to its hypertension drug Exforge.

    Midday Stock Slump 2006

  • Tekturna and Exforge are both treatments for high blood pressure.

    Novartis' Recent Selloff Seen As Buying Opportunity 2006

  • "In our view, this seems excessive as we estimate Novartis offers the second fastest five-year earnings growth in the sector after Roche and we expect several positive catalysts by the end of the year including the approval of Tekturna and Exforge," wrote analyst Alexandra Hauber in a client report.

    Novartis' Recent Selloff Seen As Buying Opportunity 2006

  • Exforge launches are ongoing in China and Japan, two key markets with particularly high use of calcium channel blockers.

    Reuters: Press Release 2011

  • Exforge, a single-pill combination of Diovan and the calcium channel blocker amlodipine, has delivered excellent growth globally since its launch in 2007.

    Reuters: Press Release 2011

  • Exforge HCT, the first modern triple hypertension medication that includes a diuretic in a single pill, is now available for patients in over 40 countries with additional launches expected over 2011 and 2012.

    Reuters: Press Release 2011

  • Exforge Group USD 317 million, +36% cc showed strong worldwide growth fueled by continued prescription demand in the EU, US and other key regions, as well as ongoing Exforge HCT launches in Europe, Asia and Latin America.

    Reuters: Press Release 2011

  • The Exforge high blood-pressure drug generated $204 million in sales.

    BusinessWeek.com -- 2010

  • In addition, Novartis Pharmaceuticals is cooperating with a US Attorney's Office for the Eastern District of Pennsylvania (EDPA) investigation into potential off-label marketing and promotion as well as payments made to healthcare providers in connection with the following products: Diovan, Exforge, Sandostatin, Tekturna and Zelnorm.

    WN.com - Business News 2010

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.